At a glance
ClinicalIndex Comparison RecordN/ACompleted· 151 enrolled
Drug / intervention
Sampling of SARS-CoV-2 RNA from nasopharyngeal swab specimen or saliva collected via Salivette Cortisolother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
COVID-19 Tests: a Systematic Comparison of Viral RNA Test Sample Taking for RT-qPCR, in This Case With a Nasopharyngeal Swab or Saliva Collected With Salivette® Cortisol, to Diagnose SARS-CoV-2 Virus Infection
In Brief
A clinical study evaluating Sampling of SARS-CoV-2 RNA from nasopharyngeal swab specimen or saliva collected via Salivette Cortisol for Covid-19. Completed, enrolled 151 participants across 1 site.
Detailed Summary
The main objective of the tests is to establish saliva collection with Salivette® Cortisol.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCovid-19
CountriesMexico
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedOct 2020
Enrollment StartOct 2020
Primary CompletionJan 2021
TodayJul 2026
First PostedOct 23, 2020
Enrollment StartOct 26, 2020
Primary CompletionJan 20, 2021
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 5.7 years ago
Interventions
Sampling of SARS-CoV-2 RNA from nasopharyngeal swab specimen or saliva collected via Salivette Cortisolother
Kylt® for detection/confirmation of SARS-CoV-2 cobas® SARS-CoV-2 (PCR) test TaqPath™ COVID-19 CE-IVD RT-PCR kit